Nimotuzumab in combination with radiotherapy in high grade glioma patients: A single institution experience

Article

Abstract: Nimotuzumab, a humanized antibody targeting epidermal growth factor receptor, has potent anti-prolif

Palabras claves:

Anaplastic astrocytoma, glioblastoma multiforme, High grade glioma, Monoclonal antibody, nimotuzumab, Radiotherapy

Autores:

Alert J., Chon I., Jorrín E., Luaces P.L.o., Marinello J.J.u., Miranda N., Solomón M.T.e., Tania Crombet

Fuentes:

scopus